I Am Heartless When It Comes To Dating

I Am Heartless When It Comes To Dating

How could she be so heartless? *Kanye voice*

Two weeks ago I was at dinner with my two of my best friends. We were reminiscing about the past and noticed a pattern in my past. When it comes to dating, I can be “heartless.” At first it stung and I was completely caught off guard with their criticism, but then I thought about it, and totally agreed. Here is why I’m heartless, and why I’m okay with it:

I am a daddy’s girl until the day I die. I love my dad not only because he’s spoiled me to no end, but he’s shown me how a woman should be treated by treating my mom with care and respect. When it was time for me to start dating, I didn’t expect any less. Now don’t get me wrong, I didn’t expect a guy to buy me a car, or flowers every other week, or anything crazy, but I expected respect, and nothing less.

As I entered high school, with hormones all weird, sometimes I would lose sight of what I deserved, but don’t worry, I quickly remembered. For example, I was with a guy for almost a year, and towards the end of our relationship he was no longer being the person he was in the beginning. The minute I realized that he was no longer treating me the way I deserved to be treated, I ended things without looking back. My friends to this day can never understand how heartless I was after I ended things. In a way, I will agree that I could have been more emotional and forgiving, but everyone handles things differently.

I don’t apologize or wish to change the way I am when it comes to dating, because I don’t believe that any person should feel their worth decrease. I also don’t believe that anyone has the right to make anyone feel worthless at anytime. Whenever I start to feel like I’m being treated badly, or I feel I’m being taken for granted, I try to confront that person and come up with a solution. I’m very direct and blunt with my feelings and thoughts, which can make me appear emotionless. I am this way partly because my dad is this way, but mostly because I never want anyone to misinterpret what I say or send any mixed messages. If I think, “Wow, this person makes me feel like sh*t,” then chances are I’m going to tell that person that they make me feel like sh*t. I would rather tell someone how I feel and find a solution then have them make me feel worthless. If we can’t find a solution that works, or there is no attempt to reach that solution, I have no problem deucing out. It may be rude or arrogant, but that is who I am. I know my self worth, and I think that everyone deserves to be treated with respect and worthy, and if someone continuously makes me feel opposite of that, I won’t tolerate it. If that makes me heartless, then I am unapologetically heartless.

Cover Image Credit: quotesgram.com

Popular Right Now

Cephalosporin Market Production Growth and Industry Analysis 2017 to 2022

A Complete overview of the Cephalosporin Market the consumers can have a clear idea about the know-how of the same.

Cephalosporin Market

GarnerInsights.com has added the report, “Cephalosporin Market : Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025” published by Reports Monitor. The far-reaching research study offers a 360-degree analysis of the market crosswise over different unequivocal elements, including market share by segmentation type, market cost analysis, market effect factors, and marketing strategy and promoting methodology.

Market Synopsis:
Cephalosporin is broad class of beta-lactam antibiotic use to combat bacterial infection by disrupting peptidoglycan synthesis primarily present in the cell wall of the bacterium. The cephalosporin antibiotic is originally obtained from the mold Acremonium which previously used to be known as cephalosporium. It is used in the treatment against staphylococcus infection, tonsillitis, bronchitis, skin infections, strep throat, gonorrhoea, pneumonia, skin infections, otitis media and many more. Cephalosporins are categorized into generations depending upon their spectrum of antimicrobial activity. First generation of cephalosporin was active against gram positive bacteria, however with newer successive generation it has increased activity against gram negative bacteria with comparatively reduced activity against gram positive once. Nonetheless, the fourth generation cephalosporins have true broad spectrum activity. 

Get Your Free Sample Copy @ http://bit.ly/2EJxpLI

Market Growth Factors:
The key factors driving the growth of this market are upsurge in incidence of infectious diseases, rise in funding for the development of antibiotics, increasing research & development activities and rising need for anti-bacterials. However, adverse side effects associated with cephalosporin such as diarrhoea, headache, vomiting, nausea, oral & vaginal candidiasis and many other restrain the further market growth. In addition, antibiotic resistance by the organism with each successive generation is reducing the impact of cephalosporin as broad spectrum antibiotic hampering growth of the market. 

The segmentation of global cephalosporin market is done on the basis of type, route of administration, application, generation and region. On the basis of type it is categorized into branded cephalosporin drug and generic cephalosporin drug. Considering the route of administration the market is divided into cephalosporin injections and oral cephalosporin drugs. On the basis of generation the cephalosporin market is separated into first, second, third, fourth and fifth generation. Depending upon the application it is differentiated into respiratory tract infection, sexually transmitted infection, ear infection, skin infection and urinary tract infection and others. 

Check for Discount of Cephalosporin Market Report @ http://bit.ly/2EHXwCE

Regional analysis:
The global cephalosporin market is studied across North America, Europe, Asia-Pacific and LAMEA. Developing economy like Asia-Pacific is highly populated with countries such as China and India. Asia-Pacific is anticipated to grow at lucrative rate owing to large population base, increase in disposable income of people and presence of unmet medical needs. 

Competitive Analysis:
The major players dominating the industry of global cephalosporin market are Allergan, Astellas, Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co., Inc., Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Pfizer, Sandoz.

Key Question for this Market Report:
What is going to the Market size as well as growth rate be in 2025?
What are the key factors driving the global Cephalosporin market?
What are the key markets trends impacting the growth of the global Cephalosporin market?
What are the challenges to market growth 2025?
Who will be the key manufacturers in this particular Market space?
What are the most important aspects driving the Global Cephalosporin Market?
What are the necessary trends impacting the build-up of the Global Cephalosporin Market?

Cephalosporin Market Analysis is expected to witness significant growth due to its rise in the application of Pharmaceuticals and Healthcare industry over the forecast period.

About Us
Garner Insights is a Market Intelligence and consulting firm with a comprehensive experience and rich knowledge of the market research industry.

Our relentless effort is to build unique solutions and constantly strive to make a difference in market intelligence.

Contact Us
Mr. Kevin Thomas
+1 513 549 5911 (US)
+44 203 318 2846 (UK)
Email: sales@garnerinsights.com
Website: http://garnerinsights.com

Related Content

Connect with a generation
of new voices.

We are students, thinkers, influencers, and communities sharing our ideas with the world. Join our platform to create and discover content that actually matters to you.

Learn more Start Creating

Anesthesia Drugs Market:2018 Global Industry Size, Trends, Demand, Manufacturers, Regions and Business Analysis 2025

OrianResearch.com announces a new report “Global Anesthesia Drugs Industry 2018 Market Research Report” added to its database.

This report provides methodically qualitative and quantitative analysis of the Anesthesia Drugs Market on a global and regional level for a period of seven years from 2018 to 2025, in terms of value and volume. The study also provides a comprehensive review of restraints, drivers and opportunities along with their impact on the overall market during the forecast period.

Get Sample copy @ – https://www.orianresearch.com/request-sample/461655 

Global Anesthesia Drugs Industry Report 2018 is a professional and in-depth study on the current state of the Anesthesia Drugs Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Anesthesia Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Complete report on Anesthesia Drugs market report spread across 115 pages, profiling 12 companies and supported with tables and figures. Enquire more @ https://www.orianresearch.com/enquiry-before-buying/461655 

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading Anesthesia Drugs Industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Anesthesia Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

Analysis of Anesthesia Drugs Industry Key Manufacturers: Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Troikaa, Claris Life sciences, Hikma Pharmaceuticals, Mylan and Nhwa.

With the list of tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. 

Purchase this report @ https://www.orianresearch.com/checkout/461655 

Table of Contents 

Global Anesthesia Drugs Sales Market Report 2018

1 Anesthesia Drugs Market Overview

2 Global Anesthesia Drugs Competition by Players/Suppliers, Type and Application

3 United States Anesthesia Drugs (Volume, Value and Sales Price)

4 China Anesthesia Drugs (Volume, Value and Sales Price)

5 Europe Anesthesia Drugs (Volume, Value and Sales Price)

6 Japan Anesthesia Drugs (Volume, Value and Sales Price)

7 Southeast Asia Anesthesia Drugs (Volume, Value and Sales Price)

8 India Anesthesia Drugs (Volume, Value and Sales Price)

9 Global Anesthesia Drugs Players/Suppliers Profiles and Sales Data

10 Anesthesia Drugs Maufacturing Cost Analysis

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

13 Market Effect Factors Analysis

14 Global Anesthesia Drugs Market Forecast (2018-2025)

15 Research Findings and Conclusion

16 Appendix.

About Us

Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President – Global Sales & Partner Relations

Orian Research Consultants

US: +1 (832) 380-8827 | UK: +44 0161-818-8027

Email: info@orianresearch.com 

Website: www.orianresearch.com/ 

Follow Us on LinkedIn: https://www.linkedin.com/company-beta/13281002/ 

Related Content

Facebook Comments